MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krause, R. M.
Right arrow Articles by Bertrand, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krause, R. M.
Right arrow Articles by Bertrand, D.

Vol. 53, Issue 2, 283-294, February 1998

Ivermectin: A Positive Allosteric Effector of the alpha 7 Neuronal Nicotinic Acetylcholine Receptor

Ryoko M. Krause, Bruno Buisson, Sonia Bertrand, Pierre-Jean Corringer, Jean-Luc Galzi,1 Jean-Pierre Changeux, and Daniel Bertrand

Department of Physiology, University Medical Center, 1211 Geneva 4, Switzerland (R.M.K., B.B., S.B., D.B.), and URA Centre National de la Recherche Scientifique D1284, Neurobiologie Moléculaire, Institut Pasteur, 75724 Paris Cedex 15, France (P.-J.C., J.-L.G., J.-P.C.)

We report that preapplication of ivermectin, in the micromolar range, strongly enhances the subsequent acetylcholine-evoked current of the neuronal chick or human alpha 7 nicotinic acetylcholine receptors reconstituted in Xenopus laevis oocytes and K-28 cells. This potentiation does not result from nonspecific Cl- currents. The concomitant increase in apparent affinity and cooperativity of the dose-response curve suggest that ivermectin acts as a positive allosteric effector. This interpretation is supported by the observation of an increase in efficiency of a partial agonist associated with the potentiation and by the differential effect of ivermectin on mutants within the M2 channel domain. Ivermectin effects reveal a novel allosteric site for pharmacological agents on neuronal alpha 7 nicotinic acetylcholine receptors.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
D. Bertrand, S. Bertrand, S. Cassar, E. Gubbins, J. Li, and M. Gopalakrishnan
Positive Allosteric Modulation of the {alpha}7 Nicotinic Acetylcholine Receptor: Ligand Interactions with Distinct Binding Sites and Evidence for a Prominent Role of the M2-M3 Segment
Mol. Pharmacol., November 1, 2008; 74(5): 1407 - 1416.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. B. Timmermann, J. H. Gronlien, K. L. Kohlhaas, E. O. Nielsen, E. Dam, T. D. Jorgensen, P. K. Ahring, D. Peters, D. Holst, J. K. Chrsitensen, et al.
An Allosteric Modulator of the {alpha}7 Nicotinic Acetylcholine Receptor Possessing Cognition-Enhancing Properties in Vivo
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 294 - 307.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Halvard Gronlien, M. Hakerud, H. Ween, K. Thorin-Hagene, C. A. Briggs, M. Gopalakrishnan, and J. Malysz
Distinct Profiles of {alpha}7 nAChR Positive Allosteric Modulation Revealed by Structurally Diverse Chemotypes
Mol. Pharmacol., September 1, 2007; 72(3): 715 - 724.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. J. Ng, E. R. Whittemore, M. B. Tran, D. J. Hogenkamp, R. S. Broide, T. B. Johnstone, L. Zheng, K. E. Stevens, and K. W. Gee
Nootropic {alpha}7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators
PNAS, May 8, 2007; 104(19): 8059 - 8064.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Sun, C. J. Lee, and H.-S. Shin
Reduced nicotinic receptor function in sympathetic ganglia is responsible for the hypothermia in the acetylcholinesterase knockout mouse
J. Physiol., February 1, 2007; 578(3): 751 - 764.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. M. Broad, R. Zwart, K. H. Pearson, M. Lee, L. Wallace, G. I. McPhie, R. Emkey, S. P. Hollinshead, C. P. Dell, S. R. Baker, et al.
Identification and Pharmacological Profile of a New Class of Selective Nicotinic Acetylcholine Receptor Potentiators
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1108 - 1117.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. A. Sim, S. Chaumont, J. Jo, L. Ulmann, M. T. Young, K. Cho, G. Buell, R. A. North, and F. Rassendren
Altered Hippocampal Synaptic Potentiation in P2X4 Knock-Out Mice.
J. Neurosci., August 30, 2006; 26(35): 9006 - 9009.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. H. Selina Mok and J. N. C. Kew
Excitation of rat hippocampal interneurons via modulation of endogenous agonist activity at the {alpha}7 nicotinic ACh receptor
J. Physiol., August 1, 2006; 574(3): 699 - 710.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Toulme, F. Soto, M. Garret, and E. Boue-Grabot
Functional Properties of Internalization-Deficient P2X4 Receptors Reveal a Novel Mechanism of Ligand-Gated Channel Facilitation by Ivermectin
Mol. Pharmacol., February 1, 2006; 69(2): 576 - 587.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Charpantier, A. Wiesner, K.-H. Huh, R. Ogier, J.-C. Hoda, G. Allaman, M. Raggenbass, D. Feuerbach, D. Bertrand, and C. Fuhrer
{alpha}7 Neuronal Nicotinic Acetylcholine Receptors Are Negatively Regulated by Tyrosine Phosphorylation and Src-Family Kinases
J. Neurosci., October 26, 2005; 25(43): 9836 - 9849.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. S. Hurst, M. Hajos, M. Raggenbass, T. M. Wall, N. R. Higdon, J. A. Lawson, K. L. Rutherford-Root, M. B. Berkenpas, W. E. Hoffmann, D. W. Piotrowski, et al.
A Novel Positive Allosteric Modulator of the {alpha}7 Neuronal Nicotinic Acetylcholine Receptor: In Vitro and In Vivo Characterization
J. Neurosci., April 27, 2005; 25(17): 4396 - 4405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Schnizler, B. Saeger, C. Pfeffer, A. Gerbaulet, U. Ebbinghaus-Kintscher, C. Methfessel, E.-M. Franken, K. Raming, C. H. Wetzel, A. Saras, et al.
A Novel Chloride Channel in Drosophila melanogaster Is Inhibited by Protons
J. Biol. Chem., April 22, 2005; 280(16): 16254 - 16262.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C.-H. Cho, W. Song, K. Leitzell, E. Teo, A. D. Meleth, M. W. Quick, and R. A. J. Lester
Rapid Upregulation of {alpha}7 Nicotinic Acetylcholine Receptors by Tyrosine Dephosphorylation
J. Neurosci., April 6, 2005; 25(14): 3712 - 3723.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. W. Lynch
Molecular Structure and Function of the Glycine Receptor Chloride Channel
Physiol Rev, October 1, 2004; 84(4): 1051 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
T. Kenakin
Allosteric Modulators: The New Generation of Receptor Antagonist
Mol. Interv., August 1, 2004; 4(4): 222 - 229.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
A. Priel and S. D. Silberberg
Mechanism of Ivermectin Facilitation of Human P2X4 Receptor Channels
J. Gen. Physiol., February 23, 2004; 123(3): 281 - 293.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. G. Conroy, Q.-S. Liu, Q. Nai, J. F. Margiotta, and D. K. Berg
Potentiation of alpha 7-Containing Nicotinic Acetylcholine Receptors by Select Albumins
Mol. Pharmacol., February 1, 2003; 63(2): 419 - 428.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. A. North
Molecular Physiology of P2X Receptors
Physiol Rev, October 1, 2002; 82(4): 1013 - 1067.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. M. Slimko, S. McKinney, D. J. Anderson, N. Davidson, and H. A. Lester
Selective Electrical Silencing of Mammalian Neurons In Vitro by the Use of Invertebrate Ligand-Gated Chloride Channels
J. Neurosci., September 1, 2002; 22(17): 7373 - 7379.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Di Angelantonio, V. Costa, P. Carloni, L. Messori, and A. Nistri
A Novel Class of Peptides with Facilitating Action on Neuronal Nicotinic Receptors of Rat Chromaffin Cells in Vitro: Functional and Molecular Dynamics Studies
Mol. Pharmacol., January 1, 2002; 61(1): 43 - 54.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. S. Khakh, G. Burnstock, C. Kennedy, B. F. King, R. A. North, P. Seguela, M. Voigt, and P. P. A. Humphrey
International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits
Pharmacol. Rev., March 1, 2001; 53(1): 107 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. S. Khakh, W. R. Proctor, T. V. Dunwiddie, C. Labarca, and H. A. Lester
Allosteric Control of Gating and Kinetics at P2X4 Receptor Channels
J. Neurosci., September 1, 1999; 19(17): 7289 - 7299.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Anand, M. E. Nelson, V. Gerzanich, G. B. Wells, and J. Lindstrom
Determinants of Channel Gating Located in the N-Terminal Extracellular Domain of Nicotinic alpha 7 Receptor
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 469 - 479.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Q. Shan, J. L. Haddrill, and J. W. Lynch
Ivermectin, an Unconventional Agonist of the Glycine Receptor Chloride Channel
J. Biol. Chem., April 13, 2001; 276(16): 12556 - 12564.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics